By Counterforce Health Team in Haegarda (C1-esterase inhibitor, SC) —

How to Get Haegarda (C1-esterase inhibitor, SC) Covered by Cigna in Ohio: Appeals, Alternatives & Success Strategies

Answer Box: Getting Haegarda Covered by Cigna in Ohio

Haegarda (C1-esterase inhibitor, SC) requires prior authorization from Cigna in Ohio. Your fastest path to approval: 1) Have your HAE specialist submit a PA request with confirmed HAE diagnosis, failed oral alternatives, and clinical rationale through Cigna's provider portal. 2) If denied, file an internal appeal within 180 days using clinical guidelines and attack frequency data. 3) Request external review through the Ohio Department of Insurance if internal appeals fail. Start today: Contact your prescriber to initiate the PA process and gather your HAE diagnosis documentation.

Table of Contents

When Alternatives Make Sense

Before pursuing Haegarda specifically, understand that Cigna covers multiple HAE prophylaxis options on their formulary. Alternatives may be appropriate if:

  • You haven't tried oral options (berotralstat/Orladeyo)
  • Injectable lanadelumab (Takhzyro) is available and suitable
  • Cost or administration preferences favor other routes
  • Your HAE specialist recommends a different first-line approach

However, Haegarda may be medically necessary when alternatives have failed, caused intolerable side effects, or aren't appropriate for your specific clinical situation.

Typical Formulary Alternatives

Cigna's 2025 formulary includes these HAE prophylaxis options:

Drug (Brand/Generic) Route Class/Mechanism Coverage Notes
Takhzyro (lanadelumab) Subcutaneous injection Plasma kallikrein inhibitor Covered with PA; preferred in many plans
Orladeyo (berotralstat) Oral daily Plasma kallikrein inhibitor Covered with PA; convenient oral option
Haegarda (C1-INH, SC) Subcutaneous injection C1 esterase inhibitor Covered with PA; twice weekly dosing
Cinryze (C1-INH, IV) Intravenous infusion C1 esterase inhibitor Covered for prophylaxis; requires IV access

Pros and Cons Overview:

  • Lanadelumab (Takhzyro): Highest efficacy (83-87% attack reduction), but injection site reactions common
  • Berotralstat (Orladeyo): Oral convenience, but moderate efficacy (44-50% reduction) and GI side effects
  • Haegarda: Strong efficacy (up to 84% reduction), established safety record, but twice-weekly injections required

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization PA required before coverage Cigna provider portal Cigna PA Policy
HAE Diagnosis Lab-confirmed HAE types 1/2 Medical records, C1-INH/C4 levels FDA Label
Specialist Prescriber Allergist/immunologist required Provider credentials Cigna Coverage Policy
Age Requirement ≥6 years old Patient age verification FDA Label
Step Therapy May require trial of alternatives Prior therapy documentation Cigna Formulary
Appeals Deadline 180 days from final denial Ohio insurance law Ohio Department of Insurance

Step-by-Step: Fastest Path to Approval

1. Confirm HAE Diagnosis Documentation

  • Who: Patient/clinic staff
  • What: Gather lab results showing low C1-INH levels/function and low C4
  • Timeline: Before PA submission
  • Submit via: Include with PA request

2. Document Prior Therapy Trials

  • Who: HAE specialist
  • What: Records of failed/intolerated alternatives (lanadelumab, berotralstat, or oral options)
  • Timeline: Ongoing clinical documentation
  • Submit via: Clinical notes with PA

3. Submit Prior Authorization Request

  • Who: Prescribing physician
  • What: Complete PA form with clinical rationale
  • Timeline: Cigna responds within 72 hours for standard requests
  • Submit via: Cigna provider portal or fax (verify current number)

4. Include Medical Necessity Letter

  • Who: HAE specialist
  • What: Detailed clinical justification citing HAE guidelines
  • Timeline: With initial PA submission
  • Submit via: Attached to PA request

5. Follow Up on PA Decision

  • Who: Patient or clinic
  • What: Check PA status and obtain written determination
  • Timeline: Within 3-5 business days
  • Submit via: Member services or provider portal

6. File Internal Appeal if Denied

  • Who: Patient or prescriber
  • What: Submit appeal with additional clinical evidence
  • Timeline: Within 180 days of denial
  • Submit via: Cigna appeals department

7. Request External Review if Needed

Tip: Use expedited review (24-hour response) if delays would seriously endanger your health.

Common Denial Reasons & Fixes

Denial Reason How to Overturn
"Not medically necessary" Submit HAE attack logs, quality of life impact, specialist letter citing international HAE guidelines
"Step therapy not met" Document failed trials of lanadelumab or berotralstat with specific adverse effects or inadequate control
"Diagnosis not confirmed" Provide lab results showing C1-INH deficiency/dysfunction and family history
"Prescriber not qualified" Ensure prescription comes from board-certified allergist/immunologist or HAE specialist
"Quantity limits exceeded" Submit weight-based dosing calculation (60 IU/kg twice weekly) with clinical justification

Appeals Playbook for Cigna in Ohio

Internal Appeals (Required First Step)

  • Level 1: Submit written appeal within 180 days of denial
  • Timeline: Cigna has 30 days to respond (expedited: 72 hours)
  • Required: Copy of denial letter, additional clinical documentation, prescriber support
  • Submit to: Cigna appeals department (address on denial letter)

Level 2 Internal Appeal

  • Timeline: 180 days from Level 1 denial
  • Process: Independent medical review by Cigna
  • Timeline: 30 days for decision (expedited: 72 hours)

External Review (Ohio Department of Insurance)

  • Eligibility: After exhausting internal appeals
  • Timeline: 180 days from final Cigna denial
  • Process: Independent Review Organization (IRO) evaluation
  • Decision timeline: 30 days standard, 72 hours expedited
  • Contact: Ohio Department of Insurance Consumer Services at 1-800-686-1526
Note: External review decisions are binding on Cigna if approved.

Exception Strategy: When to Request Haegarda

Request Haegarda specifically when:

  • Lanadelumab caused persistent injection site reactions or systemic side effects
  • Berotralstat resulted in significant GI intolerance or inadequate attack control
  • Patient requires twice-weekly dosing flexibility vs. every-2-week schedule
  • Clinical preference for C1-INH mechanism over kallikrein inhibition
  • Previous positive response to IV C1-INH (Cinryze) suggests SC C1-INH efficacy

Evidence that strengthens your request:

  • Attack frequency logs showing >2 attacks per month on current therapy
  • Documentation of emergency department visits or hospitalizations
  • Quality of life questionnaires (AE-QoL) showing significant impact
  • Specialist letter referencing published HAE management guidelines
  • Weight-based dosing calculations supporting medical necessity

At Counterforce Health, we help patients and clinicians build evidence-backed appeals for specialty medications like Haegarda. Our platform analyzes denial letters and creates targeted rebuttals using the right clinical citations and payer-specific requirements.

Switching Logistics & Coordination

If transitioning from another HAE prophylaxis:

  1. Coordinate timing with your HAE specialist to prevent breakthrough attacks
  2. Notify Accredo or current specialty pharmacy about the medication change
  3. Submit new prescription for Haegarda with updated PA request
  4. Plan overlap period if clinically appropriate during transition
  5. Monitor attack frequency closely during the first month

Accredo Specialty Pharmacy Coordination:

  • Use Accredo's Haegarda referral form for streamlined processing
  • Coordinate benefits verification and shipment logistics
  • Arrange nursing support for injection training if needed
  • Set up adherence monitoring and refill reminders

Re-trying for Haegarda Later

If initially denied, document during alternative therapy:

  • Attack logs: Frequency, severity, duration, triggers
  • Side effects: Any adverse reactions to current therapy
  • Quality of life impact: Work/school absences, activity limitations
  • Healthcare utilization: ED visits, urgent care, hospitalizations
  • Adherence challenges: Issues with current medication regimen

When to resubmit:

  • After 3-6 months of documented inadequate control on alternatives
  • Following significant adverse events on current therapy
  • When clinical guidelines are updated supporting C1-INH use
  • If insurance formulary changes improve Haegarda access

FAQ

How long does Cigna prior authorization take in Ohio? Standard PA requests: 72 hours. Expedited requests (if medically urgent): 24 hours. Source: Cigna PA Policy

What if Haegarda isn't on my specific Cigna formulary? Request a formulary exception with clinical justification. Cigna must respond within 72 hours and provide coverage if medically necessary.

Can I get expedited appeals in Ohio? Yes, if delays would seriously jeopardize your health. Both Cigna internal appeals and Ohio external reviews offer expedited timelines.

Does step therapy apply if I failed therapies in another state? Yes, documented treatment failures from any location should count toward step therapy requirements. Ensure medical records are transferred.

What's the difference between internal and external appeals? Internal appeals are reviewed by Cigna. External appeals go through Ohio's Independent Review Organization and are binding if approved.

How much does Haegarda cost without insurance? Retail cost is typically in the high four- to five-figure range monthly, varying by weight and dosing. CSL Behring patient assistance programs may help with costs.

Can my primary care doctor prescribe Haegarda? Most Cigna policies require prescription by or consultation with an allergist/immunologist or HAE specialist.

What happens if Ohio external review denies my appeal? You retain the right to pursue other remedies, including regulatory complaints or legal action, though external review is usually the final administrative step.

From our advocates: We've seen cases where patients initially denied for Haegarda succeeded on appeal by providing detailed attack logs showing breakthrough symptoms on alternatives, combined with specialist letters citing specific HAE management guidelines. The key was demonstrating that alternative therapies weren't achieving adequate disease control despite appropriate dosing and duration.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider and insurance company for personalized guidance. For additional help with insurance appeals in Ohio, contact the Ohio Department of Insurance Consumer Services at 1-800-686-1526.

Getting the right treatment approved shouldn't feel impossible. Counterforce Health specializes in turning insurance denials into successful appeals by analyzing payer policies and building evidence-backed cases for patients who need access to critical medications like Haegarda.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.